GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Flerie AB (OSTO:FLERIE) » Definitions » Institutional Ownership

Flerie AB (OSTO:FLERIE) Institutional Ownership : 3.84% (As of Apr. 27, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Flerie AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Flerie AB's institutional ownership is 3.84%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Flerie AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Flerie AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Flerie AB Institutional Ownership Historical Data

The historical data trend for Flerie AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flerie AB Institutional Ownership Chart

Flerie AB Historical Data

The historical data trend for Flerie AB can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 2.59 2.68 2.69 2.70 2.58 3.07 3.88 3.88 3.84 3.84

Flerie AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Flerie AB Business Description

Traded in Other Exchanges
Address
Skeppsbron 16, Stockholm, SWE, 111 30
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations.

Flerie AB Headlines

No Headlines